BioMarin Pharmaceutical Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| NOVO B | Novo Nordisk A/S | Outperform |
12
|
kr911.50 | Buy/Sell | kr696.07 | 5.87% | 14 | kr4.04T |
| PFE | Pfizer | Outperform |
2
|
$27.82 | Buy/Sell | $32.87 | 9.53% | 6 | $157.64B |
| SAN | Sanofi | Outperform |
16
|
87.71€ | Buy/Sell | 102.80€ | 24.27% | 9 | 109.65€B |
| CSL | CSL | Outperform |
12
|
$278.20 | Buy/Sell | $205.51 | -26.15% | 5 | $134.44B |
| 4568 | Daiichi Sankyo Company | Buy |
4
|
¥5.45k | Buy/Sell | ¥5.24k | 13.72% | 0 | ¥10.45T |
| MRNA | Moderna | Outperform |
16
|
$147.92 | Buy/Sell | $135.42 | -14.82% | 1 | $56.69B |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.11k | Buy/Sell | ¥4.74k | 11.84% | 0 | ¥6.45T |
| BIIB | Biogen | Outperform |
10
|
$214.41 | Buy/Sell | $299.62 | 34.56% | 13 | $31.22B |
| BAYN | Bayer | Hold |
5
|
26.93€ | Buy/Sell | 45.15€ | 13.26% | 4 | 26.45€B |
| ALNY | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$146.93 | Buy/Sell | $245.24 | 48.03% | 7 | $18.59B |
| SRPT | Sarepta Therapeutics | Outperform |
6
|
$116.25 | Buy/Sell | $158.66 | 42.80% | 6 | $12.51B |
| SOBI | Swedish Orphan Biovitrum AB (p... | Outperform |
16
|
kr272.80 | Buy/Sell | kr293.00 | 19.13% | 6 | kr96.39B |
| GRF | Grifols | Outperform |
18
|
9.01€ | Buy/Sell | 18.48€ | 108.66% | 3 | 5.85€B |
| IONS | Ionis Pharmaceuticals | Outperform |
9
|
$36.45 | Buy/Sell | $55.60 | 64.61% | 3 | $5.76B |
| NTLA | Intellia Therapeutics | Outperform |
8
|
$21.67 | Buy/Sell | $75.84 | 223.03% | 21 | $2.36B |
| DYN | Dyne Therapeutics | Buy |
5
|
$31.08 | Buy/Sell | $28.13 | 41.57% | 0 | $2.27B |
| DCPH | Deciphera Pharmaceuticals | Hold |
6
|
$25.51 | Buy/Sell | $23.40 | 1.92% | 4 | $2.19B |
| 4516 | Nippon Shinyaku | Outperform |
18
|
¥2.79k | Buy/Sell | ¥8.34k | 82.86% | 0 | ¥261.33B |
| BCRX | BioCryst Pharmaceuticals | Outperform |
7
|
$6.15 | Buy/Sell | $14.09 | 78.86% | 2 | $1.09B |
| WVE | Wave Life Sciences | Outperform |
6
|
$6.00 | Buy/Sell | $9.21 | 100.00% | 3 | $688.23M |
| PHARM | Pharming Group N.V. | Buy |
16
|
0.81€ | Buy/Sell | 1.85€ | 153.09% | 2 | 591.95€M |
| STOK | Stoke Therapeutics | Buy |
4
|
$13.77 | Buy/Sell | $19.33 | 45.24% | 3 | $604.59M |
| ABUS | Arbutus Biopharma | Outperform |
9
|
$3.36 | Buy/Sell | $6.34 | 63.10% | 0 | $535.96M |
| KALV | KalVista Pharmaceuticals | Buy |
7
|
$11.15 | Buy/Sell | $20.80 | 213.90% | 0 | $478.84M |
| FULC | Fulcrum Therapeutics | Outperform |
9
|
$7.77 | Buy/Sell | $10.21 | 93.05% | 7 | $456.83M |
| PYC | PYC Therapeutics | Buy |
8
|
$0.11 | Buy/Sell | $0.30 | 209.09% | 1 | $294.90M |